These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11929337)

  • 1. Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.
    Drosos AA
    Drugs; 2002; 62(6):891-907. PubMed ID: 11929337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy in children.
    Prasad R; Singh UK; Mittal R; Mishra OP
    J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 4. Signal transduction by IL-2 and its receptors as target in treatment of rheumatoid arthritis.
    Kozanidou VI; Theocharis AD; Georgiadis A; Voulgari PV; Drosos AA; Karamanos NK
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):41-50. PubMed ID: 15777203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer immunosuppressive drugs: a review.
    Gummert JF; Ikonen T; Morris RE
    J Am Soc Nephrol; 1999 Jun; 10(6):1366-80. PubMed ID: 10361877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPKs and their relevance to arthritis and inflammation.
    Thalhamer T; McGrath MA; Harnett MM
    Rheumatology (Oxford); 2008 Apr; 47(4):409-14. PubMed ID: 18187523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
    Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
    Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targets for rheumatoid arthritis: Progress and promises.
    Alghasham A; Rasheed Z
    Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL; Valesini G
    BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
    Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract]   [Full Text] [Related]  

  • 14. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging treatments for rheumatoid arthritis.
    Schiff M
    Am J Med; 1997 Jan; 102(1A):11S-15S. PubMed ID: 9217554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected cytokine pathways in rheumatoid arthritis.
    Noack M; Miossec P
    Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
    Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
    Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction in rheumatoid arthritis.
    Sweeney SE; Firestein GS
    Curr Opin Rheumatol; 2004 May; 16(3):231-7. PubMed ID: 15103250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
    Tanaka Y; Suzuki K; Saito K
    Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.